Presentations and Reports
Presentations
Cymat Investor Presentation
Q1 2024
Financial Reports
Cymat’s fiscal year commences on the first day of May and ends on the last day of April. As an example, fiscal 2019, began on May 1, 2018 and concluded on April 30, 2019.
Q3 MD&A Quarter Ended January 31, 2019
Unaudited Interim Financial Statements – January 31, 2019 and January 31, 2018
Information Circular – October 11, 2018
Q2 MD&A Quarter Ended October 31, 2018
Unaudited Interim Financial Statements – October 31, 2018 and October 31, 2017
Q1 MD&A Quarter Ended July 31, 2018
Unaudited Interim Financial Statements – July 31, 2018 and July 31, 2017
Q1 Financial Statements Quarter Ended July 31, 2016
Q1 MD&A Quarter Ended July 31, 2016
Q2 Financial Statements Quarter Ended October 31, 2016
Q2 MD&A Quarter Ended October 31, 2016
Q3 Financial Statements Quarter Ended January 31, 2017
Q3 MD&A Quarter Ended January 31, 2017
Annual Audited Financial Statements Year Ended April 30, 2017
Q1 Financial Statements Quarter Ended July 31, 2015
Q1 MD&A Quarter Ended July 31, 2015
Q2 Financial Statements Quarter Ended October 31, 2015
Q2 MD&A Quarter Ended October 31, 2015
Q3 Financial Statements Quarter Ended January 31, 2016
Q3 MD&A Quarter Ended January 31, 2016
Annual Audited Financial Statements Year Ended April 30, 2016
Q1 Financial Statements Quarter Ended July 31, 2014
Q1 MD&A Quarter Ended July 31, 2014
Q2 Financial Statements Quarter Ended October 31, 2014
Q2 MD&A Quarter Ended October 31, 2014
Q3 Financial Statements Quarter Ended January 31, 2015
Q3 MD&A Quarter Ended January 31, 2015
Annual Audited Financial Statements Year Ended April 30, 2015